Broadening the diagnostic approach for SARS-CoV-2 associated myopathy and rhabdomyolysis

Finsterer, Josef; Almas, Talal

Broadening the diagnostic approach for SARS-CoV-2 associated myopathy and rhabdomyolysis

journal contribution

posted on 2022-02-10, 07:39 authored by Josef Finsterer, Talal Almas

With interest, we read the article by Sabljic et al. about a 63-year-old female with a second renal transplant under mycophenolate mofetil, tacrolimus, and steroids, who experienced a severe SARS-CoV-2 infection manifesting as pneumonia. Her COVID-19 infection was managed with ceftriaxone, remdesivir, dexamethasone, tacrolimus reduction, and discontinuation of mycophenolate mofetil. A few days after discharge, the patient developed proximal quadriparesis and rhabdomyolysis. The study is appealing but raises comments and concerns.

History

Comments

This is the peer reviewed version of the following article: Finsterer J, Almas T. Broadening the diagnostic approach for SARS-CoV-2 associated myopathy and rhabdomyolysis. Ther Apher Dial. 2021 Nov 14:10.1111/1744-9987.13758., which has been published in final form at https://doi.org/10.1111/1744-9987.13758 . This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.

Published Citation

Finsterer J, Almas T. Broadening the diagnostic approach for SARS-CoV-2 associated myopathy and rhabdomyolysis. Ther Apher Dial. 2021 Nov 14:10.1111/1744-9987.13758.